mRNA-vaccines can efficiently activate both components of the immune system, i.e., T-cell and humoral responses. The essential advantage of mRNA vaccines includes fast, inexpensive, scalable and uniform production providing a large output of desirable products in vitro. Synthesis and purification processes significantly simplify the process technology of mRNA drugs with injectable purity. Thus, mRNA production via in vitro transcription is more advantageous as compared with DNA-vaccines since it is a chemical process without the use of cells. mRNA techniques make it possible to pass all the phases of vaccine development much faster in comparison with the production of vaccines based on inactivated viruses or recombinant proteins. This property is critically important when designing vaccines against viral pathogens as the main problem of disease control includes a time gap between an epidemic and vaccine development. mRNA vaccine core enzyme is the key raw material in the production of mRNA vaccine and drugs.
The global mRNA Vaccine Core Enzyme market was valued at US$ 2400 million in 2023 and is anticipated to reach US$ 1726 million by 2030, witnessing a CAGR of -2.5% during the forecast period 2024-2030.
The core manufacturers of mRNA Vaccine Core Enzyme mainly include Thermo Fisher, NEB, TriLink Bio Technologies, Merck, etc. The top four companies in the industry account for about 49% of the market. North America is the largest market, accounting for about 38% of the global market share. In terms of product type, Capping Enzyme have the largest market share of about 25%. From an application perspective, Biopharmaceutical Companies account for the largest share at around 84%.
This report aims to provide a comprehensive presentation of the global market for mRNA Vaccine Core Enzyme, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccine Core Enzyme.
The mRNA Vaccine Core Enzyme market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Vaccine Core Enzyme market comprehensively. Regional market sizes, concerning products by Enzyme Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Vaccine Core Enzyme manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Enzyme Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio
Yeasen Biotechnology
by Enzyme Type
Capping Enzyme
2'-O-Methyltransferase
Inorganic Pyrophosphatase
Poly (A) Polymerase
Rnase Inhibitor
RNA Polymerase
Restriction Enzyme
Dnase I
Others
by Application
Biopharmaceutical Companies
Academic and Research Institutions
Production by Region
North America
Europe
China
Latin America
Middle East & Africa
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Enzyme Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of mRNA Vaccine Core Enzyme manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of mRNA Vaccine Core Enzyme in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Enzyme Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 mRNA Vaccine Core Enzyme Market Overview
1.1 Product Definition
1.2 mRNA Vaccine Core Enzyme by Enzyme Type
1.2.1 Global mRNA Vaccine Core Enzyme Market Value Comparison by Enzyme Type (2024-2030)
1.2.2 Capping Enzyme
1.2.3 2'-O-Methyltransferase
1.2.4 Inorganic Pyrophosphatase
1.2.5 Poly (A) Polymerase
1.2.6 Rnase Inhibitor
1.2.7 RNA Polymerase
1.2.8 Restriction Enzyme
1.2.9 Dnase I
1.2.10 Others
1.3 mRNA Vaccine Core Enzyme by Application
1.3.1 Global mRNA Vaccine Core Enzyme Market Value by Application (2024-2030)
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutions
1.4 Global mRNA Vaccine Core Enzyme Market Size Estimates and Forecasts
1.4.1 Global mRNA Vaccine Core Enzyme Revenue 2019-2030
1.4.2 Global mRNA Vaccine Core Enzyme Sales 2019-2030
1.4.3 Global mRNA Vaccine Core Enzyme Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 mRNA Vaccine Core Enzyme Market Competition by Manufacturers
2.1 Global mRNA Vaccine Core Enzyme Sales Market Share by Manufacturers (2019-2024)
2.2 Global mRNA Vaccine Core Enzyme Revenue Market Share by Manufacturers (2019-2024)
2.3 Global mRNA Vaccine Core Enzyme Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of mRNA Vaccine Core Enzyme, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of mRNA Vaccine Core Enzyme, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of mRNA Vaccine Core Enzyme, Product Type & Application
2.7 Global Key Manufacturers of mRNA Vaccine Core Enzyme, Date of Enter into This Industry
2.8 Global mRNA Vaccine Core Enzyme Market Competitive Situation and Trends
2.8.1 Global mRNA Vaccine Core Enzyme Market Concentration Rate
2.8.2 The Global 5 and 10 Largest mRNA Vaccine Core Enzyme Players Market Share by Revenue
2.8.3 Global mRNA Vaccine Core Enzyme Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global mRNA Vaccine Core Enzyme Market Scenario by Region
3.1 Global mRNA Vaccine Core Enzyme Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global mRNA Vaccine Core Enzyme Sales by Region: 2019-2030
3.2.1 Global mRNA Vaccine Core Enzyme Sales by Region: 2019-2024
3.2.2 Global mRNA Vaccine Core Enzyme Sales by Region: 2025-2030
3.3 Global mRNA Vaccine Core Enzyme Revenue by Region: 2019-2030
3.3.1 Global mRNA Vaccine Core Enzyme Revenue by Region: 2019-2024
3.3.2 Global mRNA Vaccine Core Enzyme Revenue by Region: 2025-2030
3.4 North America mRNA Vaccine Core Enzyme Market Facts & Figures by Country
3.4.1 North America mRNA Vaccine Core Enzyme Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America mRNA Vaccine Core Enzyme Sales by Country (2019-2030)
3.4.3 North America mRNA Vaccine Core Enzyme Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe mRNA Vaccine Core Enzyme Market Facts & Figures by Country
3.5.1 Europe mRNA Vaccine Core Enzyme Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe mRNA Vaccine Core Enzyme Sales by Country (2019-2030)
3.5.3 Europe mRNA Vaccine Core Enzyme Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific mRNA Vaccine Core Enzyme Market Facts & Figures by Region
3.6.1 Asia Pacific mRNA Vaccine Core Enzyme Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific mRNA Vaccine Core Enzyme Sales by Region (2019-2030)
3.6.3 Asia Pacific mRNA Vaccine Core Enzyme Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America mRNA Vaccine Core Enzyme Market Facts & Figures by Country
3.7.1 Latin America mRNA Vaccine Core Enzyme Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America mRNA Vaccine Core Enzyme Sales by Country (2019-2030)
3.7.3 Latin America mRNA Vaccine Core Enzyme Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa mRNA Vaccine Core Enzyme Market Facts & Figures by Country
3.8.1 Middle East and Africa mRNA Vaccine Core Enzyme Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa mRNA Vaccine Core Enzyme Sales by Country (2019-2030)
3.8.3 Middle East and Africa mRNA Vaccine Core Enzyme Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Enzyme Type
4.1 Global mRNA Vaccine Core Enzyme Sales by Enzyme Type (2019-2030)
4.1.1 Global mRNA Vaccine Core Enzyme Sales by Enzyme Type (2019-2024)
4.1.2 Global mRNA Vaccine Core Enzyme Sales by Enzyme Type (2025-2030)
4.1.3 Global mRNA Vaccine Core Enzyme Sales Market Share by Enzyme Type (2019-2030)
4.2 Global mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2019-2030)
4.2.1 Global mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2019-2024)
4.2.2 Global mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2025-2030)
4.2.3 Global mRNA Vaccine Core Enzyme Revenue Market Share by Enzyme Type (2019-2030)
4.3 Global mRNA Vaccine Core Enzyme Price by Enzyme Type (2019-2030)
5 Segment by Application
5.1 Global mRNA Vaccine Core Enzyme Sales by Application (2019-2030)
5.1.1 Global mRNA Vaccine Core Enzyme Sales by Application (2019-2024)
5.1.2 Global mRNA Vaccine Core Enzyme Sales by Application (2025-2030)
5.1.3 Global mRNA Vaccine Core Enzyme Sales Market Share by Application (2019-2030)
5.2 Global mRNA Vaccine Core Enzyme Revenue by Application (2019-2030)
5.2.1 Global mRNA Vaccine Core Enzyme Revenue by Application (2019-2024)
5.2.2 Global mRNA Vaccine Core Enzyme Revenue by Application (2025-2030)
5.2.3 Global mRNA Vaccine Core Enzyme Revenue Market Share by Application (2019-2030)
5.3 Global mRNA Vaccine Core Enzyme Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Company Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thermo Fisher mRNA Vaccine Core Enzyme Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 NEB
6.2.1 NEB Company Information
6.2.2 NEB Description and Business Overview
6.2.3 NEB mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.2.4 NEB mRNA Vaccine Core Enzyme Product Portfolio
6.2.5 NEB Recent Developments/Updates
6.3 TriLink Bio Technologies
6.3.1 TriLink Bio Technologies Company Information
6.3.2 TriLink Bio Technologies Description and Business Overview
6.3.3 TriLink Bio Technologies mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TriLink Bio Technologies mRNA Vaccine Core Enzyme Product Portfolio
6.3.5 TriLink Bio Technologies Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck mRNA Vaccine Core Enzyme Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Aldevron
6.5.1 Aldevron Company Information
6.5.2 Aldevron Description and Business Overview
6.5.3 Aldevron mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aldevron mRNA Vaccine Core Enzyme Product Portfolio
6.5.5 Aldevron Recent Developments/Updates
6.6 Qiagen N.V.
6.6.1 Qiagen N.V. Company Information
6.6.2 Qiagen N.V. Description and Business Overview
6.6.3 Qiagen N.V. mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Qiagen N.V. mRNA Vaccine Core Enzyme Product Portfolio
6.6.5 Qiagen N.V. Recent Developments/Updates
6.7 Promega
6.7.1 Promega Company Information
6.7.2 Promega Description and Business Overview
6.7.3 Promega mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Promega mRNA Vaccine Core Enzyme Product Portfolio
6.7.5 Promega Recent Developments/Updates
6.8 Roche CustomBiotech
6.8.1 Roche CustomBiotech Company Information
6.8.2 Roche CustomBiotech Description and Business Overview
6.8.3 Roche CustomBiotech mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Roche CustomBiotech mRNA Vaccine Core Enzyme Product Portfolio
6.8.5 Roche CustomBiotech Recent Developments/Updates
6.9 Takara Bio Inc.
6.9.1 Takara Bio Inc. Company Information
6.9.2 Takara Bio Inc. Description and Business Overview
6.9.3 Takara Bio Inc. mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Takara Bio Inc. mRNA Vaccine Core Enzyme Product Portfolio
6.9.5 Takara Bio Inc. Recent Developments/Updates
6.10 Novoprotein
6.10.1 Novoprotein Company Information
6.10.2 Novoprotein Description and Business Overview
6.10.3 Novoprotein mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novoprotein mRNA Vaccine Core Enzyme Product Portfolio
6.10.5 Novoprotein Recent Developments/Updates
6.11 Vazyme
6.11.1 Vazyme Company Information
6.11.2 Vazyme Description and Business Overview
6.11.3 Vazyme mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Vazyme mRNA Vaccine Core Enzyme Product Portfolio
6.11.5 Vazyme Recent Developments/Updates
6.12 Hongene Biotech Corporatio
6.12.1 Hongene Biotech Corporatio Company Information
6.12.2 Hongene Biotech Corporatio Description and Business Overview
6.12.3 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product Portfolio
6.12.5 Hongene Biotech Corporatio Recent Developments/Updates
6.13 Yeasen Biotechnology
6.13.1 Yeasen Biotechnology Company Information
6.13.2 Yeasen Biotechnology Description and Business Overview
6.13.3 Yeasen Biotechnology mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Yeasen Biotechnology mRNA Vaccine Core Enzyme Product Portfolio
6.13.5 Yeasen Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 mRNA Vaccine Core Enzyme Industry Chain Analysis
7.2 mRNA Vaccine Core Enzyme Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 mRNA Vaccine Core Enzyme Production Mode & Process
7.4 mRNA Vaccine Core Enzyme Sales and Marketing
7.4.1 mRNA Vaccine Core Enzyme Sales Channels
7.4.2 mRNA Vaccine Core Enzyme Distributors
7.5 mRNA Vaccine Core Enzyme Customers
8 mRNA Vaccine Core Enzyme Market Dynamics
8.1 mRNA Vaccine Core Enzyme Industry Trends
8.2 mRNA Vaccine Core Enzyme Market Drivers
8.3 mRNA Vaccine Core Enzyme Market Challenges
8.4 mRNA Vaccine Core Enzyme Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio
Yeasen Biotechnology
*If Applicable.